ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1072

Enzymatic Lipid Oxidation Contributes to the Maintenance of Self-Tolerance by Regulating Antigen Clearance and Dendritic Cell Function

Stefan Uderhardt1, Tobias Rothe1, Elisabeth Zinser2, Olga Oskolkova3, Martin Herrmann4, Alexander Steinkasserer5, Valery Bochkov3, Georg Schett6 and Gerhard Kronke1, 1Internal Medicine 3, University of Erlangen, Erlangen, Germany, 2University of Erlangen, Erlangen, Germany, 3Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 4Instiute for Immunology, PhD, Erlangen, Germany, 5Department of Immune Modulation at the Department of Dermatology, University Hospital Erlangen, Erlangen, Germany, 6Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: antigen-presenting cells, Auto-immunity, immune response, lipids and monocytes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

During inflammation and tissue damage, pathogens as well as dying cells are ingested by different phagocytes such as macrophages and dendritic cells. The uptake of particles and subsequent presentation of derived antigens by antigen presenting cells (APC) are key events in the initiation of an adaptive immune response. Thus, both the nature and the activation state of the respective phagocyte determine the resulting immune response ranging from specific immunity to tolerance. However, defects and alterations of these processes are associated with chronic inflammation and autoimmunity. Specific lipid oxidation products, generated by the enzyme 12/15-lipoxygenase (12/15-LO) were implicated in the active resolution of inflammation and limitation of inflammation-associated tissue damage. In this study, we investigated the potential role of enzymatic lipid oxidation by 12/15-LO during initiation of an adaptive immune response and the maintenance of self-tolerance.

Methods:

We studied both the clearance of AC and pathogens, as well as the maturation and function of monocyte-derived, antigen-presenting phagocytes in wildtype and 12/15-LO -/- animals in vitro and in vivo, respectively.

Results:

We observed a pivotal role of 12/15-LO in the maintenance of self-tolerance as aged 12/15-LO-deficient mice spontaneously developed autoimmune features indicating a break of self-tolerance. Moreover, a loss of 12/15-LO resulted in an exacerbation of a murine disease model of experimental autoimmune encephalomyelitis (EAE), which resembles clinical and pathological hallmarks of human multiple sclerosis.

Consistently, 12/15-LO -/- mice showed a disturbed clearance of AC under inflammatory conditions, with a clear shift of phagocytosis towards pro-inflammatory antigen-presenting cells. In addition, we could detect a marked expression of 12/15-LO in in vitro-generated bone marrow-derived dendritic cells (BMDC). Interestingly, BMDC isolated from 12/15-LO -/- mice presented an increased expression of co-stimulatory molecules on their surface, accompanied by an altered pro-inflammatory cytokine profile. Under inflammatory conditions, the uptake of AC-derived model-antigens by APC from 12/15-LO -/- mice resulted in an increased antigen presentation and subsequent T cell activation, both in vitro and in vivo. By adding 12/15-LO-generated phospholipid oxidation products, we were, in turn, able to restore an anti-inflammatory clearance of AC in vitro and in vivo, down-regulate co-stimulatory markers expressed by APC and, thereby, limit T cell activation in vitro.

Conclusion:

Together, these data indicate a potential regulatory role of enzymatic lipid oxidation by 12/15-LO during the initiation of an adaptive immune response by both orchestrating a cell- and context-specific clearance of antigens by different phagocyte subsets and regulating the maturation and activation status of the respective APC.


Disclosure:

S. Uderhardt,
None;

T. Rothe,
None;

E. Zinser,
None;

O. Oskolkova,
None;

M. Herrmann,
None;

A. Steinkasserer,
None;

V. Bochkov,
None;

G. Schett,
None;

G. Kronke,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enzymatic-lipid-oxidation-contributes-to-the-maintenance-of-self-tolerance-by-regulating-antigen-clearance-and-dendritic-cell-function/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology